fate stock price target

FATE was reported by Morgan Stanley on September 9 2022The analyst firm set a price target for 3500 expecting. What are analysts forecasts for Fate Therapeutics stock.

Fed Raises Rates And Projects Six More Increases In 2022 The New York Times

Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on.

. The 24 analysts offering price forecasts for Fate Therapeutics have a median target of 8758 with a high estimate of. What is the target price for Fate Therapeutics FATE stock. A The latest price target for Fate Therapeutics NASDAQ.

This is based on 10 Wall Streets Analysts 12-month price targets issued in the past 3 months. FATE stock forecast and price target. In comparison to the median Healthcare stock FATEs pricesales ratio is 48298 higher now standing at 274.

This is 453 less than the trading day before Tuesday 1st Nov. Fate Therapeutics stock forecast analyst price target predictions based on 12 analysts offering 12-months price targets for FATE in the last 3 months. Stock Price Target FATE.

See Fate Therapeutics Inc. For more insight on analysts targets of FATE see our FATE price target. The forecasts range from a low of 2800 to a high of.

The highest analyst price target. Analyst ratings historical stock prices earnings estimates actuals. Fate Therapeutics NASDAQFATE Get Rating had its price target trimmed by Citigroup from 8700 to 8000 in a report issued on Wednesday The Fly reports.

The average price target for Fate Therapeutics is 7250. 28 rows The Trend in the Analyst Price Target. FATE updated stock price target summary.

FATEs average price target has moved. Based on short-term price targets offered by 16 analysts the average price target for Fate Therapeutics comes to 6275. FATE stock analyst estimates including earnings and revenue EPS upgrades and downgrades.

8 Wall Street analysts that have issued a 1 year FATE price target the average FATE price target is 7150 with the highest FATE stock price forecast at 11500 and the. Find the latest Fate Therapeutics Inc. Fate Therapeutics stock forecast analyst price target predictions based on 11 analysts offering 12-months price targets for FATE in the last 3 months.

Fate Therapeutics Inc FATE Stock Analysis Based on the Fate Therapeutics Inc stock forecasts from 8 analysts the average analyst target price for Fate Therapeutics Inc is USD. Analyst estimates including FATE earnings per share estimates and analyst recommendations. FATE analyst stock forecast price target and recommendation trends with.

The latest price target for. Close price at the end of the last trading day Wednesday 2nd Nov 2022 of the FATE stock was 2004. The average stock valuation materialised ratio is 6664 and average time for PT to be met is 12789 days.

FATE was reported by Cantor Fitzgerald on Friday.

Fate Stock Price And Chart Nasdaq Fate Tradingview